TrialDiabetes, obesity & metabolism2021

MRI measures of hypothalamic injury are associated with glucagon-like peptide-1 receptor agonist treatment response in people with hypothalamic obesity.

Francisco A Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.